Tanvex BioPharma, Inc. announced the resignation of Ken Huang as Accounting officer, effective January 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.55 TWD | +1.28% | -2.57% | -33.10% |
14/03 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
06/02 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
1st Jan change | Capi. | |
---|---|---|
-33.10% | 22Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-2.79% | 2.19TCr | |
-12.15% | 2.23TCr | |
-5.38% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer